BioMérieux announced on Tuesday that its BioFire SpotFire Respiratory Panel Mini has obtained CLIA wavier from the US Food and Drug Administration.

The US Food and Drug Administration (FDA) has granted approval for Foundation Medicine’s FoundationOne Liquid CDx as a companion diagnostic for Takeda’s Exkivity (mobocertinib).

Veracyte, Inc. today announced financial results for the first quarter ended March 31, 2023.

On April 25-26, Yin Ye, CEO of BGI Genomics, and his delegation visited Serbia and signed a memorandum of understanding with the Serbian Ministry of Health on cooperation in public health and precision testing.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the first quarter ended March 31, 2023.

BD, a leading global medical technology company, today announced results for its second quarter of fiscal 2023, which ended March 31, 2023.

The World Health Organization on Friday announced that COVID-19 is no longer a global emergency, marking a symbolic end to the pandemic, which has taken 7 million lives around the world. The move is deemed a natural one given the current stable situation.

A spokesperson from Beijing Strong Biotechnologies, Inc. (hereinafter referred to as BSBE) recently responded to investors' questions about chemiluminescence at the 2022 Annual Investor Exchange.

QIAGEN announced results for the first quarter of 2023.

Werfen on Thursday announced a partnership agreement with Thermo Fisher Scientific for worldwide distribution of the TCAutomation laboratory automation system as part of the HemoCell Specialized Lab Automation system for hemostasis diagnostic testing.

On April 28, Lifotronic Technology Co., Ltd. released its 2022 annual report.

Lucira Health, which broke new ground in 2020 with the first rapid at-home COVID-19 test but filed for bankruptcy this year, said in a recent US Securities and Exchange Commission filing that it has been acquired by Pfizer for $36.4 million through a bankruptcy auction.

QuidelOrtho Corporation, a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced financial results for the first quarter ended April 2, 2023.

Cytiva and the life sciences business of Pall Corporation have completed their integration and are now united as one business under the Cytiva brand.

On April 27, Mindray released its annual report, showing that in 2022, it achieved revenue of 30.366 billion CNY, up 20.17% year-on-year, net profit attributable to shareholders of the listed company was 9.607 billion CNY, up 20.07% year-on-year; net cash flow from operating activities was 12.141 billion CNY, up 34.92% year-on-year, and basic earnings per share was 7.94 CNY.